Abstract:The trial was conducted to study on the effects of different type of sodium butyrate on serum bio-chemical indices, antioxidant and anti-inflammatory function of broilers challenged with lipopolysaccharide ( LPS) . Feeding trial: a total of 1 000 one-day-old Lingnan yellow broilers were randomly allocated into 5 groups with 4 replicates in each group and 50 broilers per replicate. Broilers in control group were fed a basal diet, the others in experimental groups were fed the basal diets supplemented with 500 mg/kg powder sodium butyrate ( NaB) , and 250, 500 and 750 mg/kg coated sodium butyrate ( CNaB) , respectively. The LPS in-jection experiment was conducted followed a 50-day feeding trial, 72 fifty-day-old female broilers were select-ed randomly from control, NaB and 250 mg/kg CNaB group with the best growth performance, with 6 broilers per replicate. And they were allotted into a 2×3 factorial arrangement with challenge status (saline or LPS ex-posure) and feed diet (0, 500 mg/kg NaB or 250 mg/kg CNaB) as main factor for endotoxin exposure test. Half of broilers in each group were injected intraperitoneally with E.coli LPS (0.5 mg/kg body weight)at 53, 56 and 59 d of age, the remaining broilers were injected intraperitoneally with the same amount of saline as the LPS injected group. The trial lasted for 10 days. The results showed as follows: 1) compared with the saline injected group, the content of glucose and riglyceride in serum was significantly decreased in LPS injected group (P<0.05), but the serum uric acid content as significantly increased (P<0.05). The serum glucose content of NaB and CNaB groups injected with LPS was significantly higher than that of control group ( P<0.05) . 2) Compared with the saline injected group, the activity of superoxide dismutase ( SOD) and glutathi-one peroxidase ( GSH-Px) in serum and liver was significantly decreased in LPS injected group ( P<0. 05 or P<0.01) , the serum catalase ( CAT) activity was significantly decreased ( P<0.05) . The activity of SOD and CAT in serum and liver of NaB and CNaB groups injected with LPS was higher than that of control group ( P>0.05), but the malonaldehyde content was lower than that of control group (P>0.05). There were a signifi-cant interaction between dietary sodium butyrate and LPS injected on liver GSH-Px activity ( P<0.05) , and the two forms of sodium butyrate exerted an equal effect on antioxidant enzyme activity. 3) Compared with the sa-line injected group, the content of ceruloplasmin and interleukin-6 in serum at the age of 53 and 59 days was significantly increased in LPS injected group ( P<0.05) . The serum ceruloplasmin content at the age of 53 days of NaB and CNaB groups injected with LPS was significantly lower than that of control group (P<0.05). In conclusion, sodium butyrate can improve the nutrient metabolism, maintain antioxidant function and promote anti-inflammation function, the effects on anti-stress of 500 mg/kg NaB are equal to those of 250 mg/kg CNaB which contains 75 mg/kg effective substance.

Sodium butyrate ameliorates lipopolysaccharide-induced cow mammary epithelial cells from oxidative stress damage and apoptosis.

Sodium Butyrate Promotes Lipopolysaccharide-Induced Innate Immune Responses by Enhancing Mitogen-Activated Protein Kinase Activation and Histone Acetylation in Bovine Mammary Epithelial Cells

Sodium Butyrate Reduces Bovine Mammary Epithelial Cell Inflammatory Responses Induced by Exogenous Lipopolysaccharide, by Inactivating NF-κB Signaling

Nrf2 Activation and NF-Kb & caspase/bax signaling inhibition by sodium butyrate alleviates LPS-induced cell injury in bovine mammary epithelial cells

Sodium Butyrate Alleviates Lipopolysaccharide-Induced Inflammatory Responses by Down-Regulation of NF-B, NLRP3 Signaling Pathway, and Activating Histone Acetylation in Bovine Macrophages

Sodium Butyrate Alleviates Lipopolysaccharide-Induced Inflammatory Responses by Down-Regulation of NF-κB, NLRP3 Signaling Pathway, and Activating Histone Acetylation in Bovine Macrophages

Efficacy of Sodium Butyrate in Alleviating Mammary Oxidative Stress Induced by Sub-Acute Ruminal Acidosis in Lactating Goats

Sodium Butyrate Induces Mitophagy and Apoptosis of Bovine Skeletal Muscle Satellite Cells through the mTOR Signaling Pathway

Butyrate alleviates oxidative stress by regulating NRF2 nuclear accumulation and H3K9/14 acetylation via GPR109A in bovine mammary epithelial cells and mammary glands.

Sodium butyrate alleviates intestinal injury and microbial flora disturbance induced by lipopolysaccharides in rats

Sodium butyrate protect bone mass in lipopolysaccharide-treated rats by reducing oxidative stress and inflammatory

Dietary Sodium Butyrate Supplementation Reduces High-Concentrate Diet Feeding-Induced Apoptosis in Mammary Cells in Dairy Goats

Sodium Butyrate Attenuates Bovine Mammary Epithelial Cell Injury by Inhibiting the Formation of Neutrophil Extracellular Traps.

Sodium Butyrate Supplementation Alleviates the Adaptive Response to Inflammation and Modulates Fatty Acid Metabolism in Lipopolysaccharide-Stimulated Bovine Hepatocytes

Sodium Butyrate Improves Antioxidant Stability in Sub-Acute Ruminal Acidosis in Dairy Goats

Effects of Different Type of Sodium Butyrate on Serum Biochemical Indices, Antioxidant and Anti-Inflammatory Function of Broilers Challenged with Lipopolysaccharide

Sodium Butyrate Attenuated Ie-Dap Induced Inflammatory Response in the Mammary Glands of Dairy Goats Fed High-Concentrate Diet.

Betaine protects bovine mammary epithelial cells against LPS-induced inflammatory response and oxidative damage via modulating NF-κB and Nrf2 signalling pathway

NOD1/NF-κB signaling pathway inhibited by sodium butyrate in the mammary gland of lactating goats during sub-acute ruminal acidosis

Study on the regulation mechanism of lipopolysaccharide on oxidative stress and lipid metabolism of bovine mammary epithelial cells

The short-chain fatty acid sodium butyrate exerts protective effects through ameliorating blood-milk barrier disruption and modulating inflammatory response in lipopolysaccharide-induced mastitis model.